First Niagara Bank’s Bristol-Myers Squibb BMY Stock Holding History

First Niagara Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$4.2M	Sell	57,100 -989	-2%	-$69.9K	1.2%	26
2016 Q1	$3.71M	Sell	58,089 -1,925	-3%	-$121K	1.09%	27
2015 Q4	$4.13M	Sell	60,014 -5,158	-8%	-$341K	1.15%	27
2015 Q3	$3.86M	Sell	65,172 -1,671	-2%	-$106K	1.01%	29
2015 Q2	$4.45M	Buy	66,843 +2,370	+4%	+$156K	1%	29
2015 Q1	$4.16M	Sell	64,473 -1,980	-3%	-$124K	0.91%	32
2014 Q4	$3.92M	Sell	66,453 -2,096	-3%	-$118K	0.84%	33
2014 Q3	$3.51M	Sell	68,549 -1,132	-2%	-$56.5K	0.74%	37
2014 Q2	$3.38M	Sell	69,681 -1,728	-2%	-$85.2K	0.7%	40
2014 Q1	$3.71M	Sell	71,409 -2,902	-4%	-$154K	0.74%	37
2013 Q4	$3.95M	Sell	74,311 -66	-0.1%	-$3.36K	0.76%	38
2013 Q3	$3.44M	Sell	74,377 -1,127	-1%	-$49.5K	0.73%	39
2013 Q2	$3.37M	Buy	+75,504	New	+$3.28M	0.71%	40

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Niagara Bank's BMY Position: Q2 2016 in Review

First Niagara Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2016, selling an estimated $69.9K and leaving 57,100 shares worth $4.2M. The position accounts for 1.2% of the portfolio, ranked #26.

First Niagara Bank first reported a position in BMY in Q2 2013 and has held it in 13 quarters since. The position peaked at $4.45M in Q2 2015. 1,577 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

First Niagara Bank held 57,100 shares of Bristol-Myers Squibb worth $4.2M as of Q2 2016.
First Niagara Bank sold 989 Bristol-Myers Squibb shares in Q2 2016, an estimated $69.9K.
Bristol-Myers Squibb made up 1.2% of First Niagara Bank's portfolio in Q2 2016, its #26 holding.
First Niagara Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 13 quarters since.
First Niagara Bank's Bristol-Myers Squibb position peaked at $4.45M in Q2 2015.
1,577 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on First Niagara Bank's 13F filing for Q2 2016, filed 25 Jul 2016.